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Abstract
Background: Prognostic value of concomitant aprtic regurgitation (AR) in patients operated for severe aortic
stenosis (AS) is not clarified. The aim of this study was to prospectively examine the impact of presence and
severity of concomitant AR in patients operated for severe AS on long-term functional capacity, left ventricular (LV)
function and mortality.
Methods: Study group consisted of 110 consecutive patients operated due to severe AS. The patients were
divided into AS group (56 patients with AS without AR or with mild AR) and AS+AR group (54 patients with AS
and moderate, severe or very severe AR). Follow-up included clinical examination, six minutes walk test (6MWT)
and echocardiography 12 and 104 months after AVR.
Results: Patients in AS group had lower LV volume indices throughout the study than patients in AS+AR group.
Patients in AS group did not have postoperative decrease in LV volume indices, whereas patients in AS+AR group
experienced decrease in LV volume indices at 12 and 104 months. Unlike LV volume indices, LV mass index was
significantly lower in both groups after 12 and 104 months as compared to preoperative values. Mean LVEF
remained unchanged in both groups throughout the study. NYHA class was improved in both groups at 12
months, but at 104 months remained improved only in patients with AS. On the other hand, distance covered
during 6MWT was longer at 104 months as compared to 12 months only in AS+AR group (p = 0,013), but patients
in AS group walked longer at 12 months than patients in AS+AR group (p = 0,002). There were 30 deaths during
study period, of which 13 (10 due to cardiovascular causes) in AS group and 17 (12 due to cardiovascular causes)
in AS+AR group. Kaplan-Meier analysis showed that the survival probability was similar between the groups.
Multivariate analysis identified diabetes mellitus (beta 1.78, p = 0.038) and LVEF < 45% (beta 1.92, p = 0.049) as the
only independent predictor of long-term mortality.
Conclusion: Our data indicate that the preoperative presence and severity of concomitant AR has no influence on
long-term postoperative outcome, LV function and functional capacity in patients undergoing AVR for severe AS.
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In routine clinical practice significant number of the
patients with aortic stenosis (AS) have concomitant aor-
tic regurgitation (AR) of different severity, which is
easily explained having in mind etiology and pathologi-
cal process responsible for development of stenosis of
effective aortic valve orifice.
According to actual guidelines for treatment of
patients with valvular heart diseases, in symptomatic
patients with confirmed AS, surgical aortic valve repla-
cement (AVR) is recommended, and the same approach
is advised in the case of combined aortic valve disease, if
the stenosis is predominant lesion [1].
Following successful AVR due to AS, in the majority
of the patients significant symptomatic and functional
improvement is noted, with significantly better long-
term survival as compared to medically treated patients
[2]. Factors that may influence outcome following AVR
include age, preoperative NYHA class, left ventricular
(LV) hypertrophy and ejection fraction (EF), heart
rhythm disturbances, preoperative pressure gradient
over aortic valve, and presence of coronary artery dis-
ease [3,4].
Prognostic value of concomitant AR in patients oper-
ated for severe AS is not clarified. Some investigators
identified preoperative presence of significant AR as a
risk factor for development of postoperative LV dysfunc-
tion, while others did not [5,6]. Impact of associated AR
on long-term survival following AVR is also controver-
sial [3,7].
Therefore, the aim of the present study was to pro-
spectively examine the impact of presence and severity
of concomitant AR in patients operated for severe AS
on long-term functional capacity, left ventricular (LV)
function and mortality.
Methods
Patients
The study population consisted of consecutive sympto-
matic patients with significant AS operated at Dedinje
Cardiovascular Institute from January 1 to December
31, 1999. The study was prospective. Inclusion criteria
included 1) mean gradient over aortic valve > 30
mmHg, 2) elective operation, 3) willingnes to sign
informed consent. Exclusion criteria were 1) significant
valvular disease, other than aortic valve, requiring sur-
gery, 2) significant AR and associated AS with mean
gradient over aortic valve ≤ 30 mmHg, 3) previous cor-
onary and/or valvular surgery. Presence of significant
coronary artery disease was not considered as exclusion
factor.
A total of 110 patients met inclusion/exclusion cri-
teria, and were included in the study. Patients were
divided in two groups: AS group - patients with isolated
symptomatic AS and significant AS with trace or mild
(1+) AR; and AS+AR group - patients with significant
AS and moderate (2+), severe (3+) or very severe (4+)
AR. Their medical records were reviewed for demo-
graphic, clinical, and ECG data.
Preoperative echocardiographic findings
Preoperative transthoracic echocardiographic assessment
included standard M mode, 2D and color Doppler study
using Sonos 2500 system (Hewlett Packard, Andover,
MA, USA). LV volumes and EF were calculated from
apical two- and four- chamber cross sections by using
Simpson`s method. The apical five-chamber and/or
suprasternal cross sections were used to obtain continu-
ous wave Doppler recordings to measure maximal velo-
city across the aortic valve. Maximal systolic pressure
gradient over aortic valve was calculated from the Dop-
pler velocities using the modified Bernoulli equation.
Aortic regurgitation was semiquantitatively assessed by
Color Doppler flow, using standard technique. The LV
mass (LVM) was calculated using the Devereux and
associates equation as: LVM = 1,04 (LVEDD + IVSTd +
PWTd)
3 × 0,8 + 0,6; where EDD = end-diastolic dimen-
sion, IVSTd = interventricular septal thickness at end-
diastole and PWTd = posterior wall thickness at end-
diastole, and corrected by ASE - cube conversion. Left
ventricle mass and volumes were adjusted to body sur-
face area and expressed as indexes. LV systolic dysfunc-
tion was defined as LVEF < 45%.
Preoperative hemodynamic and angiographic findings
Preoperative invasive diagnostic included standard left
cardiac catheterization with aortic root and coronary
artery angiography in all patients. Pressure gradient was
measured directly and aortic regurgitation was semi-
quantified as 0, 1+, 2+, 3+ i 4+. Coronary artery disease
was defined as ≥ 50% lumen diameter narrowing of the
left main coronary artery or ≥ 70% lumen diameter nar-
rowing of at least one of the major epicardial vessels.
Multivessel coronary artery disease was defined as either
left main or two or three major epicardial vessel disease.
In the case of disagreement with the estimation of the
aortic regurgitation between echocardiographic and
angiographic assessment, angiographic result was used
for further analysis.
Operative data
Aortic valve replacements were done by standard surgi-
cal procedure with cardiopulmonary bypass and cardio-
plegia. Mechanical prosthesis was implanted to all of the
patients. Most often used prosthesis was Medtronic
Hall, and rarely St. Jude or Carbomedicis. If indicated,
concomitant coronary artery bypass surgery was per-
formed at the same time as AVR, using standard
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diac surgeons, and the details of preoperative patient
management were left to the discretion of the attending
physician.
Follow-up
The first control examination was done 12 ± 3 months
following surgery with 101 patients (1 patient lost to fol-
low-up). Two patients died during the first postoperative
year, and the data for time and cause of death were
reviewed from the relevant medical documentation, sup-
plied by patient’s families. Examination included clinical
assessment, ECG, echocardiography and six minute walk
test (6MWT). The test was performed per protocol of
Lipkin and associates [8], with encouragement during
the test. Three patients were not willing to cooperate
during the test and their results were excluded from
further analysis.
The second control examination was done 104 ± 3
months after operation with 79 patients. A total of 22
patients who died during period between two follow up
examinations, and the data for time and cause of death
were reviewed from the relevant medical documenta-
tion, supplied by patient’s families. The protocol was the
same as for the first control examination. Echocardio-
graphy was performed by Vivid 4 system (General Elec-
tric, Milwaukee, WI, USA) for ehocardiographic
assessment. Two patients were not willing to cooperate
during 6MWT and their results were excluded from
further analysis.
Statistical analysis
Data are expressed as mean value ± standard deviation
for continuous variables, and the paired and unpaired
Student t-test was performed to determine intra- and
intergroup differences between mean values. For catego-
rical variables data are expressed as numbers with per-
centage, and were analyzed by chi-square test or Fisher’s
exact test, as appropriate. Predictors of long-term survi-
val was tested using a univariate and multivariate analy-
sis. Variables with p < 0,1 in univariate were included in
multivariate analysis. A p < 0,05 in multivariate analysis
was considered statistically significant. Survival was esti-
mated by the use of Kaplan - Meier method, and a dif-
ference between survival curves was tested with a long-
rank test. All statistics were processed by a standard sta-
tistical software package (SPSS release 10, SSPS Inc.,
Chicago, IL, USA).
Results
Preoperative and operative characteristics
Preoperative patient`s characteristics are presented in
Table 1. Briefly, patients in AS group were significantly
older and had more frequently hypertension. Patients in
AS+AR group had significantly higher mean left ventri-
cular end-diastolic volume index (EDVi), mean left ven-
tricular end-systolic volume index (ESVi) and left
ventricular mass index (LVMi). There were no differ-
ences between the group with respect to other preopera-
tive variables.
The total operative mortality was 5% (6/110 patients).
The operative mortality was similar in AS and AS+AR
group (1.8% vs 9.2%, respectively, p = 0,084). Addition-
ally, there were no differences between the groups with
respect to other operative characteristics (Table 2).
Follow-up data
Changes in LVEDVi and LVESVi during follow-up per-
iod are shown on Figure 1. It can be appreciated that
the patients in AS group had lower LV volume indices
throughout the study than patients in AS+AR group.
On the other hand, patients in AS group did not have
postoperative decrease in LV volume indices, whereas
patients in AS+AR group experienced decrease in LV
volume indices at 12 months, which was evident also
after 8 years postoperatively at 104 months. Figure 2
depicts changes in LVMi during the study. Unlike LV
volume indices, LVMi was significantly lower in both
groups after 12 and 104 months as compared to preo-
perative values. Additionally, LVMi was lower preopera-
tively and 12 months after AVR in patients with AS
alone in comparison with patients with AS+AR, but at
104 months LVMi was similar between the groups.
Mean LVEF remained unchanged in both groups
throughout the study, as well as the number of patients
with depressed LVEF (predefined as <45%) (Table 3).
As shown in Table 3, NYHA class was improved in
both groups at 12 months, but at 104 months remained
improved only in patients with AS. On the other hand,
distance covered during 6MWT was longer at 104
months as compared to 12 months only in AS+AR group
(p = 0,013), but patients in AS group walked longer at 12
months than patients in AS+AR group (p = 0,002).
During the course of the study only 1 patient was lost
to follow-up (0.9%). There were 30 deaths, of which 13
(10 due to cardiovascular causes) in AS group and 17
(12 due to cardiovascular causes) in AS+AR group.
Kaplan-Meier analysis showed that the survival probabil-
ity was similar between the groups (Figure 3).
In order to assess prognostic impact of preoperative
demographic, clinical, echocardiographic and angio-
graphic variables, we tested a number of these variables
in univariate model (age, sex, NYHA class, symptoms
duration, hypertension, diabetes mellitus, hyperlipopro-
teinemia, atrial fibrillation, presence and severity of asso-
ciated aortic regurgitation, LV volume indices, LVEF, LV
systolic dysfunction (LVEF < 45%), LV mass index, max-
imal and mean pressure gradient over aortic valve,
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ables, only diabetes mellitus (beta 1.62, p = 0.044), preo-
perative LVEF (beta -1.19, p = 0.063) and LVEF < 45%
(beta 2.23, p = 0.015) emerged as univarite predictors of
long-term mortality and were entered in multivariate
model. Multivariate analysis identified diabetes mellitus
(beta 1.78, p = 0.038) and LVEF < 45% (beta 1.92, p =
0.049) as the only independent predictor of long-term
mortality.
Discussion
Our data indicate that the preoperative presence and
severity of concomitant ARh a sn oi n f l u e n c eo nl o n g -
term postoperative outcome, LV function and functional
capacity in patients undergoing AVR for severe AS.
Preoperative characteristics of both groups in our
s t u d yw e r es i m i l a re x c e p tf o rt h ea g e( A Sg r o u po l d e r )
and LV volume indices (higher in AS+AR group). The
reason for the discrepancy in age is probably the fact
that AS in older patients is most commonly
Table 1 Preoperative demographic, clinical, echocardiographic, angiographic and haemodynamic data
overall AS AS+AR p
Number of patients 110 56 54
Age (years) mean ± S.D. 60,5 ± 9,4 64,2 ± 5,64 56,7 ± 11,0 0,00003
Sex (n,% female) 33 (30) 21 (38) 12 (22) 0,0805
NYHA class mean ± S.D. 2,39 ± 0,49 2,34 ± 0,48 2,44 ± 0,50 0,7207
Symptoms (months) mean ± S.D. 18,1 ± 15,9 20,2 ± 16,8 15,9 ± 14,6 0,1599
Hypertension n,(%) 39 (35) 29 (52) 10 (18) 0,0003
Diabetes mellitus n,(%) 7 (10) 6 (11) 1 (2) 0,0569
Hiperlipoproteinemia n,(%) 23 (41) 15 (27) 8 (14) 0,1227
Bicuspid aortic valve n,(%) 33 (30) 11 (20) 20 (37) 0,0426
Atrial fibrilation n,(%) 4 (4) 3 (5) 1 (2) 0,3262
LV EDVi (ml/m
2) mean ± S.D. 81,7 ± 21,2 71,3 ± 16,0 92,6 ± 29,2 0,0001
LV ESVi (ml/m²) mean ± S.D. 35,1 ± 15,4 28,9 ± 13,7 41,5 ± 22,9 0,0008
LV EF (%) mean ± S.D. 59 ± 14 60 ± 13 57 ± 15 0,2192
LV EF < 45% n,(%) 18 (16) 7 (13) 11 (20) 0,2646
LVMi (g/m²) mean ± S.D. 112,3 ± 20,5 106,9 ± 19,0 117,93 ± 20,6 0,0046
ΔP eho max (mmHg) mean ± S.D. 98 ± 29 98 ± 22 98 ± 35 0,9894
ΔP eho mean (mmHg) mean ± S.D. 63 ± 19 63 ± 16 62 ± 22 0,9393
Coronary artery disease n,(%) 29 (26) 18 (32) 11 (20) 0,1454
ΔP cath (mmHg) mean ± S.D. 85,3 ± 28,3 89,7 ± 25,8 81,1 ± 30,3 0,2455
Abbreviations: LV - left ventricle, EDVi -end-diastolic volume index, ESVi -end-systolic volume index, EF - ejection fraction, LVMi -left ventricular mass index, DP -pressure
gradient, eho - echocardiografic, cath - catheterization, S.D. - standard deviation.
Table 2 Operative characteristics
overall AS AS+AR p
Prosthesis type n, (%)
Medtronic Hall 96 (87) 50 (90) 46 (85) 0,5189
Carbomedicis 4 (4) 1 (2) 3 (6) 0,2998
St.Jude 10 (9) 5 (9) 5 (9) 0,9519
Prosthesis size (mm) 22,62 ±
1,90
22,13 ±
1,83
23,13 ±
1,85
0,9231
Prosthesis size/BSA (mm/
m²)
12,20 ±
1,21
12,19 ±
1,23
12,20 ±
1,19
0,9531
Bypass surgery n, (%) 22 (20) 12 (21) 10 (19) 0,7029
Single bypass 4 (4) 2 (3) 2 (4) 0,3886
Double bypass 12 (11) 5 (9) 7 (13) 0,4974
Triple bypass 6 (5) 5 (9) 1 (2) 0,1023
Operative mortality n, (%) 6 (5) 1 (2) 5 (9) 0,0844
Abbreviations: BSA - body surface area
Figure 1 Change of mean LV end-diastolic and end-systolic
volume indexes during follow up period. Abbreviations: AR,
aortic regurgitation; AS, aortic stenosis; EDVi, end-diastolic volume
index, ESVi, end-systolic volume index; LV, left ventricle. P* marks
difference between groups, p
1 marks difference between
preoperative values and values on the first control, p
2 marks
difference between preoperative values and values on the second
control
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of the valve leaflets [9], while in younger patients it is
mostly due to congenital aortic valve diseases [9]. Addi-
tionally, coexisting AR is more frequent in younger
patients [9], which is similar to the findings of our
study. Significantly higher preoperative LV volumes and
pronounced LV hypertrophy in patients with AS and
coexisting significant AR, in relation to patients with
isolated AS, was also noted in earlier reports [5,6].
There is ongoing controversy with respect to the
impact of perioperative AR on long-term outcome fol-
lowing AVR due to severe AS. For the problem to be
worse, it is difficult to make direct comparisons of dif-
ferent studies due to differences in the methodology.
For example, some studies who examined outcome after
AVR for AS included only patients with associated mild
AR, [3,6], whereas other studies included patients
regardless of the degree of associated AR [10]. Some
authors separately analyzed patients with pure AS and
patients with AS and mild or moderate, [11] while other
authors analyzed only patients with AS and moderate or
severe AR [5]. Previous studies identified sex, pressure
gradient over aortic valve, type and size of the implanted
prosthesis, and the incidence of associated coronary
artery bypass surgery as a predictors of long term out-
come of surgery [3,4,12,13]. Our data suggest that there
is no difference in perioperative mortality between the
AS and AS+AR groups, which is similar to previously
reported paper [14].
Additionally, univariate and mulivariate analysis in our
study failed to identify associated aortic regurgitation as
a risk factor for long-term survival. The fact that univar-
ite predictors of long-term mortality were diabetes mel-
litus, preoperative LVEF and LVEF < 45%, as well as
that only diabetes mellitus and LVEF < 45% were identi-
fied as the only independent predictor of long-term
mortality, are in concordance with previous studies [3].
The process of LV remodeling after AVR, in the sense
of reduction of volumes, is most intense during first
postoperative year [10,15,16], which is consistent with
our findnigs. Despite pronounced reduction of LV
volumes in AS+AR group, they were significantly higher
than in AS group on both of the follow up examina-
tions. This is in accordance to findings of other authors
who followed patients with similar characteristics [5,6].
Although evident difference in LV volume indices was
noted between the groups, there was no difference in
LVEF and the number of patients with impaired LV
function. Therefore, it can be postulated that in patients
with AS and appropriate preoperative LV adaptation,
capable to preserve LV systolic function, postoperative
LV function will also be preserved regardless to the
degree of coexisting AR. In other words, in patient with
AS, if preoperative LV adaptation is appropriate, similar
long term outcome according to LV systolic function
Figure 2 Change of LV mass index during during follow up
period. For abbreviations and details see Figure 1.
Table 3 Results on control examinations according to
defined outcomes
Outcome Group Preoperatively First
control
Second
control
NYHA class
mean ± s.d.
AS 2,34 ± 0,48 1,98 ± 0,42
1 2,07 ± 0,46
1
AS + AR 2,44 ± 0,50 2,08 ± 0,45
1 2,22 ± 0,58
6MWT (m)
mean ± s.d.
AS nd 322 ± 96 340 ± 100
AS + AR nd 276 ± 106
3 325 ± 89
2
LV EF (%)
mean ± s.d.
AS 60 ± 13 62 ± 11 60 ± 10
AS + AR 57 ± 15 60 ± 11 57 ± 11
LV EF <
45%
n, (%)
AS 7 (13) 3 (8) 2 (6)
AS + AR 11 (20) 3 (9) 4 (12)
Dead n, (%) AS - 1 (2) 12 (22)
AS + AR - 1 (2) 12 (24)
Abbreviations: nd, not done;
1 p < 0.001 vs preoperative values;
2 p < 0.05 vs
AS group;
3 p < 0.05 vs first control.
Figure 3 Kaplan - Meier survival curves following surgery; a
comparison of the patients with preoperative isolated aortic
stenosis versus aortic stenosis with associated significant aortic
regurgitation For abbreviations see Figure 1.
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adaptation. Also, it is well known that AVR due to AS
has favorable impact on LV function and survival in the
patients with reduced LV function [17,18].
In our study, postoperative LVMi was decreased in
relation to preoperative values on both of follow up
examinations, in both of the groups. This was not sur-
prising, as regression of LV hypertrophy after surgery
due to AS was previously confirmed by many investiga-
tors [19-21]. One year after AVR mean LVMi was sig-
nificantly higher in AS+AR group, but at 104 months
there was no difference between groups according to
LVMi, which is similar to findings of Waszyrowski with
associates [15]. Obviously LV readaptation following
AVR, in patients with isolated AS and AS with conco-
mitant AR, has different time course [6,21].
In the majority of patients AVR due to AS is followed
by significant symptomatic improvement [5,17,18],
where personal perception of improvement of the exer-
cise tolerance was achieved mostly during the first post-
operative year. Gradual, albeight non-statistically
significant, increase in NYHA class in both groups in
our study between two control examinations is most
likely due to the fact that there was almost 8 years gap
between the examinations, and that patients got older
which might change personal perception of their exer-
cise tolerance.
Objective measures of functional capacity, such as
6MWT, are rarely performed in follow-up of patients
with AVR due to severe AS. It is well known that in
heart failure patients 6MWT can identify patients with
increased risk of mortality and morbidity [22,23]. are
showed prognostic value of 6MWT in relation to survi-
val in patients with heart failure. We have shown that
distance covered during 6MWT was longer at 104
months as compared to 12 months only in AS+AR
group, but patients in AS group walked longer at 12
months than patients in AS+AR group. The possible
clinical importance of these data is not clear, but may
reflect LV diastolic properties which were not assessed
in this study. This issue is very important and merits
further investigation in appropriately designed studies.
In this paper we showed favorable effect of AVR due
to AS regarding long term survival, as it was confirmed
in many other studies. In research of Craver and associ-
ates [9], in which the patients with AS and coexisting
AR were observed jointly regardless of degree of asso-
ciated AR, one year postoperative survival was 91% and
8-years survival was 76%. In research of Lund [3], in
patients with AS and associated mild and moderate AR,
5-years postoperative survival was 85% and 10-years
68%. We did not find significant difference regarding
long term survival between the groups, so it appears
that preoperative presence of hemodinamically
significant AR in patients with AS has no influence on
long-term postoperative survival. This is a very contro-
versial issue, since only one paper is in according with
this finding, [3] while other authors identify associated
AR as a risk factor for worse survival [7].
In conclusion, our data indicate that the preoperative
presence and severity of concomitant AR has no influ-
ence on long-term postoperative outcome, LV function
and functional capacity in patients undergoing AVR for
severe AS.
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